Six million donkeys slaughtered annually for Chinese medicine
Almost six million donkeys are slaughtered annually for Chinese medicine, with severe knock-on effects for African villagers who rely on the animals, a UK-based charity said on Thursday.
It is driven by an increase in China's production of ejiao -- a product marketed as a health supplement that uses collagen from donkey skins -- which is a $6.8-billion industry, according to China-based research firm Qianzhan.
China, whose donkey population has plummeted from 11 million in 1992 to 1.5 million in 2023, has turned to Africa to meet its demand.
With donkey populations falling, the African Union issued a 15-year moratorium on donkey slaughter last year.
UK-based charity The Donkey Sanctuary said "the ejiao industry drives a massive global trade in donkey skins, much of it illegal".
It said around 5.9 million donkeys were killed worldwide last year.
The ejiao trade is expected to require at least 6.8 million donkey skins by 2027.
The rising value of donkeys means they have increasingly become targets for criminals.
"Traders exploit vulnerable people using large and sophisticated networks of agents to pressure donkey owners into selling their animals," the charity said.
"Illegal networks operate across the continent, often without consequence, stealing and slaughtering donkeys in the night," it added.
"Donkeys die in often unregulated, inhumane, and unsanitary conditions, and large numbers perish on their way to slaughterhouses," it continued.
The impact on humans is particularly felt by women and children, who rely on donkeys for farming activities such as ploughing and for carrying goods to market.
The criminal operations also generated health risks, The Donkey Sanctuary said.
"The transportation of untreated skins and improper disposal of donkey carcasses risk triggering the spread of infectious diseases and damaging local ecosystems."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
2 hours ago
- Gulf Today
Six million donkeys slaughtered for Chinese medicine: Charity
Almost six million donkeys are slaughtered annually for Chinese medicine, with severe knock-on effects for African villagers who rely on the animals, a UK-based charity said on Thursday. It is driven by an increase in China's production of ejiao — a product marketed as a health supplement that uses collagen from donkey skins — which is a $6.8-billion industry, according to China-based research firm Qianzhan. China, whose donkey population has plummeted from 11 million in 1992 to 1.5 million in 2023, has turned to Africa to meet its demand. With donkey populations falling, the African Union issued a 15-year moratorium on donkey slaughter last year. UK-based charity The Donkey Sanctuary said "the ejiao industry drives a massive global trade in donkey skins, much of it illegal." It said around 5.9 million donkeys were killed worldwide last year. The ejiao trade is expected to require at least 6.8 million donkey skins by 2027. The rising value of donkeys means they have increasingly become targets for criminals. A man rides a donkey-pulled cart carrying corn husks along the banks of the Rio Bravo after heavy rains, in Ciudad Juarez, Mexico. Reuters "Traders exploit vulnerable people using large and sophisticated networks of agents to pressure donkey owners into selling their animals," the charity said. "Illegal networks operate across the continent, often without consequence, stealing and slaughtering donkeys in the night," it added. "Donkeys die in often unregulated, inhumane, and unsanitary conditions, and large numbers perish on their way to slaughterhouses," it continued. The impact on humans is particularly felt by women and children, who rely on donkeys for farming activities such as ploughing and for carrying goods to market. The criminal operations also generated health risks, The Donkey Sanctuary said. "The transportation of untreated skins and improper disposal of donkey carcasses risk triggering the spread of infectious diseases and damaging local ecosystems." Agence France-Presse
Zawya
11 hours ago
- Zawya
Siemens Healthineers unveils latest AI-powered healthcare innovations at Africa Health Excon 2025
Cairo, Egypt – Siemens Healthineers, a global leader in medical technology, is participating in Africa Health Excon 2025, held under the patronage of H.E. President Abdel Fattah El-Sisi from June 24 to 27 at the Egypt International Exhibition Center (EIEC). During the exhibition, Dr. Khaled Abdel Ghaffar, the Deputy Prime Minister and Minister of Health and Population, and Dr. Hisham Stait, Chairman of the Egyptian Authority for Unified Procurement (UPA), visited the Siemens Healthineers Egypt booth to explore the company's latest AI-powered solutions and groundbreaking healthcare technologies. This year, Siemens Healthineers is showcasing its advanced portfolio of digital healthcare solutions, reinforcing its commitment to driving the digital transformation of the healthcare sector in Egypt and the wider region. Siemens Healthineers is participating with two dedicated booths; the main booth highlights the company's state-of-the-art diagnostic and interventional imaging solutions, while the second booth focuses on next-generation laboratory diagnostic technologies. Among the key innovations unveiled is the MAGNETOM Flow™ Elite, a 1.5 Tesla MRI scanner with a 70 cm bore that operates without the need for helium refills—enhancing operational efficiency and delivering high-quality diagnostic imaging. The company also introduces the NAEOTOM the world's first photon-counting computed tomography (CT) scanner. Powered by AI, it delivers unprecedented imaging precision, streamlines workflows, and supports clinical decision-making. Another highlight is the SOMATOM a mobile CT scanner with a telescopic design, enabling accurate imaging directly in critical care settings such as intensive care units and ambulances. Siemens Healthineers is also showcasing a comprehensive portfolio of imaging solutions, including the MOBILETT Elara Max™ mobile X-ray system, ACUSON Sequoia™ and ACUSON Juniper™ ultrasound platforms, and molecular imagining mini mockups of Symbia and Biograph Trinion™. The Diagnostic Experience booth features new laboratory innovations such as the CN-3000 pioneering solutions such as the CN-3000 Atellica coagulation analyzer, Atellica HEMA 580 and Atellica HEMA 530 hematology analyzers, alongside the HEMATEK 3000 sedimentation and Atellica CI chemistry analyzers. These innovations reflect Siemens Healthineers' full-spectrum diagnostic capabilities, and its mission in supporting the development of Egypt's healthcare system and providing integrated diagnostic solutions that enable early disease detection, improve patient outcomes, and expand access to high-quality healthcare across Egypt. Eng. Amro Kandil, CEO and Managing Director of Siemens Healthineers Egypt, commented: 'Our annual participation in Africa Health Excon reflects our unwavering commitment to transforming Egypt's healthcare sector through innovation, strategic partnerships, and capacity building. This year, we are proud to announce the launch of the region's first center Advanced Imaging Renewal and Enhancement Center for the development and refurbishment of medical imaging devices, right here in Egypt. Established in partnership with the Ministry of Health and Population and the Unified Procurement Authority, this center will elevate healthcare service quality by reconditioning medical equipment to global standards—offering cost-effective solutions that meet Egypt's healthcare needs.' Kandil added: 'We also continue to invest in human capital through the expansion of the Siemens Healthineers Academy in Egypt, which is set to become a regional education and development center, serving both Africa and the Middle East. Empowering healthcare professionals is essential to building a sustainable, future-ready healthcare system.' Diaa El-Shennawy, Head of Sales Public Sector, NGOs & Government Affairs, said: 'Africa Health Excon provides a valuable platform to foster collaboration and support Egypt's healthcare development priorities. At Siemens Healthineers, we remain dedicated to offering tailored solutions that address the unique needs of Egypt's healthcare system, delivering advanced medical technologies that improve service efficiency and sustainability.' Siemens Healthineers continues to play an active role in supporting Egypt's national & presidential healthcare initiatives, including the Women's Health Initiative and the Early Detection and Treatment of Cancer Initiative. The company is also contributing to the establishment of a nationwide network of specialized stroke centers, offering advanced solutions like the Artis Icono Pro™, which is already operational at the Ain Shams University Stroke Center to enable faster diagnosis and intervention. Following its acquisition of Varian, Siemens Healthineers has further expanded its portfolio to include cutting-edge cancer treatment solutions and precision medicine, strengthening its ability to provide a fully integrated spectrum of diagnostic and therapeutic solutions tailored to Egypt's evolving healthcare landscape. Through its continued focus on innovation, partnerships, local capacity building, and broadening access to high-quality healthcare, Siemens Healthineers reaffirms its deep commitment to advancing the sustainability and resilience of Egypt's healthcare system. About: Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at
Khaleej Times
14 hours ago
- Khaleej Times
Six million donkeys slaughtered annually for Chinese medicine
Almost six million donkeys are slaughtered annually for Chinese medicine, with severe knock-on effects for African villagers who rely on the animals, a UK-based charity said on Thursday. It is driven by an increase in China's production of ejiao -- a product marketed as a health supplement that uses collagen from donkey skins -- which is a $6.8-billion industry, according to China-based research firm Qianzhan. China, whose donkey population has plummeted from 11 million in 1992 to 1.5 million in 2023, has turned to Africa to meet its demand. With donkey populations falling, the African Union issued a 15-year moratorium on donkey slaughter last year. UK-based charity The Donkey Sanctuary said "the ejiao industry drives a massive global trade in donkey skins, much of it illegal". It said around 5.9 million donkeys were killed worldwide last year. The ejiao trade is expected to require at least 6.8 million donkey skins by 2027. The rising value of donkeys means they have increasingly become targets for criminals. "Traders exploit vulnerable people using large and sophisticated networks of agents to pressure donkey owners into selling their animals," the charity said. "Illegal networks operate across the continent, often without consequence, stealing and slaughtering donkeys in the night," it added. "Donkeys die in often unregulated, inhumane, and unsanitary conditions, and large numbers perish on their way to slaughterhouses," it continued. The impact on humans is particularly felt by women and children, who rely on donkeys for farming activities such as ploughing and for carrying goods to market. The criminal operations also generated health risks, The Donkey Sanctuary said. "The transportation of untreated skins and improper disposal of donkey carcasses risk triggering the spread of infectious diseases and damaging local ecosystems."
